Related Experiment Video

Updated: Jun 1, 2026

Spatial and Temporal Analysis of Active ERK in the C. elegans Germline
08:40

Spatial and Temporal Analysis of Active ERK in the C. elegans Germline

Published on: November 29, 2016

ARF triggers cell G1 arrest by a P53 independent ERK pathway

Hansong Du1, Weiqi Yao, Min Fang

  • 1Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan, People's Republic of China.

Molecular and Cellular Biochemistry
|June 11, 2011
PubMed

Insights

This study shows that p14ARF inhibits cell growth and DNA synthesis in p53-deficient cells by activating the MEK/ERK pathway and p21. This demonstrates p14ARF

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • The tumor suppressor protein p53 is crucial in preventing cancer.
  • p14ARF is a known tumor suppressor that can function independently of p53.
  • Understanding p53-independent functions is vital for developing new cancer therapies.

Purpose of the Study:

  • To investigate the p53-independent functions of p14ARF.
  • To elucidate the molecular mechanisms underlying p14ARF-induced cell cycle arrest in p53-deficient cells.
  • To determine the role of the MEK/ERK pathway in p14ARF's tumor suppressive activity.

Main Methods:

  • Established p14ARF-inducible HCT cell lines using a doxycycline-inducible system.
  • Utilized p53-deficient (p53-/-) HCT cells.
  • Assessed cell growth, DNA synthesis, and cell cycle progression (G1/S arrest).
  • Analyzed the activation of the MEK/ERK pathway and p21 expression.

Main Results:

  • p14ARF induction in p53-/- HCT cells strongly inhibited cell growth and induced G1/S arrest.
  • A significant decrease in DNA synthesis was observed post-induction.
  • Activation of ERK1/2 and p21 was confirmed upon p14ARF induction.
  • The MEK/ERK pathway and p21 were demonstrated to mediate p14ARF's p53-independent functions.

Conclusions:

  • p14ARF exhibits potent tumor suppressive functions independent of p53.
  • The MEK/ERK pathway and p21 play critical roles in mediating p14ARF's p53-independent anti-cancer effects.
  • These findings highlight potential therapeutic strategies targeting the p14ARF pathway in p53-deficient cancers.

More Related Videos

A Functional Assay for Gap Junctional Examination; Electroporation of Adherent Cells on Indium-Tin Oxide11:02

A Functional Assay for Gap Junctional Examination; Electroporation of Adherent Cells on Indium-Tin Oxide

Published on: October 18, 2014

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

Related Concept Videos

DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...